Rajat Mohanka, n/a
NYIT College of Osteopathic Medicine
Disclosure(s): No financial relationships to disclose
Bedros Taslakian, MD, EBIR
Director of VIR Research Program; Director of Clinical Research Integration
NYU Grossman School of Medicine Program
Frederic Bertino, MD
Clinical Assistant Professor; Director of Pediatric Interventional Radiology
Department of Radiology at NYU Grossman School of Medicine
Review the diagnosis, classifications, and medical management of PE
Review the current literature regarding the use of anticoagulation, thrombolytics and mechanical thrombectomy
Understand the pathophysiology of CTEPH and its implications for various treatment options
Appreciate the value of ongoing clinical trials and implications for future directions in the management of VTE
At the conclusion of this educational exhibit, the reader should:
Understand the current schema of clinical risk stratification of PE.
Be familiar with the current care standard for the medical therapy of patients with PE.
Understand the spectrum of novel devices and their safety, efficacy, and limitations for percutaneous catheter directed thrombolysis and mechanical thrombectomy.
Risk-stratify patients and identify treatment modalities based on the body of literature and experience from other institutions.
Be familiar with upcoming clinical trials that will better guide the management for PE patients.
Understand how the pathophysiology of CTEPH may have a role in the chosen modality based on the presence or absence of patient risk factors
With multiple treatment options for VTE at the interventional radiologist’s disposal, a better understanding of the efficacy, safety, and indications for each therapy will aid the interventional radiologist in treating patients with PE.